Join
Live feed
·
PRReleasevia Quantisnow
Actinium Pharmaceuticals Inc. (Delaware) logo

Actinium Pharmaceuticals to Present ATNM-400 Program Update at SNMMI 2026 Conference on May 31-June 2 and Provides NYSE American Listing Standards Notice

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATNM (Actinium Pharmaceuticals Inc. (Delaware)) and more on Quantisnow.